Prevalence of retinopathy of prematurity in Iran: a systematic review and Meta-analysis

Saman Maroufizadeh1, Amir Almasi-Hashiani1, Reza Omani Samani1

  • 1Department of Epidemiology and Reproductive Health, Reproductive Epidemiology Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran 16635-148, Iran.

Insights

The overall prevalence of retinopathy of prematurity (ROP) in Iran is 26.1%. Key risk factors include low birth weight and gestational age, necessitating improved care for preterm infants to reduce ROP incidence.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Public Health

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
  • Understanding the prevalence of ROP is crucial for developing targeted public health interventions.
  • Previous estimates of ROP prevalence in Iran were limited and lacked comprehensive analysis.

Purpose of the Study:

  • To determine the overall prevalence of retinopathy of prematurity (ROP) in Iran.
  • To synthesize existing data through a systematic review and Meta-analysis.
  • To identify potential risk factors and inform preventive strategies for ROP.

Main Methods:

  • A systematic review and Meta-analysis of published studies on ROP prevalence in Iran.
  • Searched international and national databases (e.g., PubMed, Scopus, IranMedex) from inception to May 2016.
  • Employed random-effects Meta-analysis to calculate the pooled prevalence, assessing heterogeneity and publication bias.

Main Results:

  • The pooled prevalence of ROP in Iran was estimated at 26.1% (95% CI: 20.3%-31.8%).
  • Substantial statistical heterogeneity was observed among the included studies (I²=97.7%).
  • Egger's test indicated the presence of publication bias (P=0.024).

Conclusions:

  • The prevalence of ROP in Iran is notably high.
  • Low birth weight and premature gestational age are identified as significant risk factors.
  • Enhanced neonatal care, particularly oxygen management, is recommended to decrease ROP rates.
Abstract